Weiyi Xia
Shanghai University(CN)Jiangsu University(CN)Chinese Academy of Medical Sciences & Peking Union Medical College(CN)First People's Hospital of Kunshan(CN)Eye & ENT Hospital of Fudan University(CN)
Publications by Year
Research Areas
Ophthalmology and Eye Disorders, Pituitary Gland Disorders and Treatments, Osteoarthritis Treatment and Mechanisms, Retinal Diseases and Treatments, Nanoplatforms for cancer theranostics
Most-Cited Works
- → Solid tumor penetration by integrin-mediated pegylated poly(trimethylene carbonate) nanoparticles loaded with paclitaxel(2012)97 cited
- → Integrin-facilitated transcytosis for enhanced penetration of advanced gliomas by poly(trimethylene carbonate)-based nanoparticles encapsulating paclitaxel(2013)80 cited
- → Chrysophanol prevents IL-1β-Induced inflammation and ECM degradation in osteoarthritis via the Sirt6/NF-κB and Nrf2/NF-κB axis(2022)38 cited
- → Intravenous route to choroidal neovascularization by macrophage-disguised nanocarriers for mTOR modulation(2021)38 cited
- → Lidocaine inhibits the progression of retinoblastoma in�vitro and in�vivo by modulating the miR‑520a‑3p/EGFR axis(2019)28 cited
- → Orientin inhibits inflammation in chondrocytes and attenuates osteoarthritis through Nrf2/NF‐κB and SIRT6/NF‐κB pathway(2023)